Mtem

Molecular Templates is a biotechnology company that develops and commercializes immunotoxins for the treatment of cancer.

Business Model:

Revenue: $35.1M

Employees: 201-500

Detailed Mtem Information

Geographic Data

Mtem headquarters map

Address: 9301 Amberglen Blvd

City: Austin

State: TX

Zip: 78729

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$76M

Raised Total:

$138M

Metrics

2,387,280Website Global Rank

7,689Website Monthly Traffic

Twitter Followers

Description

Molecular Templates is a biotechnology company that develops and commercializes immunotoxins for the treatment of cancer.

Contact Phone:
+15128961555

Contact Email:

Mtem went public on 3/17/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/17/2017

Ticker Symbol:
MTEM

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
12/2015 Series D 1 $4.5M Sante Ventures
Sante Ventures
Sante Ventures
Sante Ventures
11/2019 Equity $15M
9/2014 Series C 2 $3.5M Aju IB Investment
Aju IB Investment
Sante Ventures
Aju IB Investment
Aju IB Investment
12/2019 Post-IPO Equity $15M
10/2013 Series C 2 $8.5M Excel Venture Management
Sante Ventures
Excel Venture Management
8/2017 Post-IPO Equity 5 $60M Longitude Capital
Perceptive Advisors
CAM Capital
Takeda
Biotechnology Value Fund
Longitude Capital
Longitude Capital
Perceptive Advisors
CAM Capital
Takeda
Biotechnology Value Fund
Longitude Capital
7/2014 Venture Round 2 $7M Excel Venture Management
Sante Ventures
Excel Venture Management
Sante Ventures
4/2011 Series B $3.5M
5/2009 Series A 1 $2.5M Sante Ventures
Sante Ventures
10/2013 Grant 1 $10.6M Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas
2/2005 IPO $37.3M
3/2018 Post-IPO Debt 1 $10M Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
Perceptive Advisors
7/2017 Equity $20M
5/2020 Debt $15M K2 HealthVentures
3/2020 Post-IPO Debt 2 $45M Frazier Healthcare Partners
K2 HealthVentures
Frazier Healthcare Partners
K2 HealthVentures
9/2018 Post-IPO Equity $52M
1/2010 Grant 1 $153.9k National Institutes of Health
National Institutes of Health
2/2021 Post-IPO Equity $75.9M
Announced Date Name Price
8/2017 Threshold Pharmaceuticals

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research